DREAM3R: Durvalumab with chemotherapy as first-line treatment in advanced pleural mesothelioma—A phase 3 randomized trial.

PM Forde, AK Nowak, PS Kok, C Brown, Z Sun… - 2021 - ascopubs.org
TPS8586 Background: Standard first line treatment for unresectable malignant pleural
mesothelioma (MPM) is platinum-based chemotherapy with pemetrexed. Two recent, single …

DREAM3R: Durvalumab with chemotherapy as first-line treatment in advanced pleural mesothelioma-A phase 3 randomized trial.

PM Forde, AK Nowak, P Kok, C Brown… - Journal of Clinical …, 2021 - eprints.qut.edu.au
Background: Standard first line treatment for unresectable malignant pleural mesothelioma
(MPM) is platinum-based chemotherapy with pemetrexed. Two recent, single-arm, phase 2 …